Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes

Detalles Bibliográficos
Autores principales: Connell, C. M., Raby, S., Beh, I., Flint, T. R., Williams, E. H., Fearon, D. T., Jodrell, D. I., Janowitz, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834107/
https://www.ncbi.nlm.nih.gov/pubmed/28430855
http://dx.doi.org/10.1093/annonc/mdx181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834107/
https://www.ncbi.nlm.nih.gov/pubmed/28430855
http://dx.doi.org/10.1093/annonc/mdx181

Ejemplares similares